Lung adenocarcinoma harboring L858R and T790M mutations in epidermal growth factor receptor, with poor response to gefitinib: A case report

Ítems similars

• L858R-positive lung adenocarcinoma with KRAS G12V, EGFR T790M and EGFR L858R mutations: A case report
  per: XIANG, XIANHONG, et al.
  Publicat: (2015)
• Unusual metachronous lung adenocarcinomas harboring EGFR L858R/T790M mutations: A case report
  per: Pei, Guotian, et al.
  Publicat: (2020)
• Acquired Gefitinib-Resistant Mutation of EGFR in a Chemonaive Lung Adenocarcinoma Harboring Gefitinib-Sensitive Mutation L858R
  per: Gow, Chien-Hung, et al.
  Publicat: (2005)
• Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib
  per: Xu, Wei, et al.
  Publicat: (2015)
• De Novo T790M Mutation in an L858R Epidermal Growth Factor Receptor Mutant-Associated Lung Adenocarcinoma
  per: Fujiwara, Takumi, et al.
  Publicat: (2020)